Description
Ziprasidone is a combined 5-HT (serotonin) and dopamine receptor antagonist like other atypical antipsychotic agents. Ziprasidone targets dopamine neurotransmission at dopamine D2 receptors which is significant for the positive symptoms of schizophrenia